BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35216319)

  • 1. MicroRNA-199b Deregulation Shows Oncogenic Properties and Promising Clinical Value as Circulating Marker in Locally Advanced Rectal Cancer Patients.
    Santos A; Cristóbal I; Rubio J; Caramés C; Luque M; Sanz-Alvarez M; Morales-Gallego M; Madoz-Gúrpide J; Rojo F; García-Foncillas J
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of microRNA-199b as A Promising Predictor of Outcome and Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer Patients.
    Cristóbal I; Santos A; Rubio J; Caramés C; Zazo S; Sanz-Álvarez M; Luque M; Madoz-Gúrpide J; Rojo F; García-Foncillas J
    Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-199b Downregulation Confers Resistance to 5-Fluorouracil Treatment and Predicts Poor Outcome and Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients.
    Cristóbal I; Rubio J; Santos A; Torrejón B; Caramés C; Imedio L; Mariblanca S; Luque M; Sanz-Alvarez M; Zazo S; Madoz-Gúrpide J; Rojo F; García-Foncillas J
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32580513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of microRNA-199a-5p is associated with superior clinical outcomes in patients with locally advanced rectal cancer.
    Baek DW; Kim G; Kang BW; Kim HJ; Park SY; Park JS; Choi GS; Kang MK; Hur K; Kim JG
    J Cancer Res Clin Oncol; 2020 Jan; 146(1):105-115. PubMed ID: 31781865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor microRNAs Identified by Small RNA Sequencing as Potential Response Predictors in Locally Advanced Rectal Cancer Patients Treated With Neoadjuvant Chemoradiotherapy.
    Machackova T; Trachtova K; Prochazka V; Grolich T; Farkasova M; Fiala L; Sefr R; Kiss I; Skrovina M; Dosoudil M; Berindan-Neagoe I; Svoboda M; Slaby O; Kala Z
    Cancer Genomics Proteomics; 2020; 17(3):249-257. PubMed ID: 32345666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating serum microRNA-345 correlates with unfavorable pathological response to preoperative chemoradiotherapy in locally advanced rectal cancer.
    Yu J; Li N; Wang X; Ren H; Wang W; Wang S; Song Y; Liu Y; Li Y; Zhou X; Luo A; Liu Z; Jin J
    Oncotarget; 2016 Sep; 7(39):64233-64243. PubMed ID: 27572313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients.
    Lopes-Ramos CM; Habr-Gama A; Quevedo Bde S; Felício NM; Bettoni F; Koyama FC; Asprino PF; Galante PA; Gama-Rodrigues J; Camargo AA; Perez RO; Parmigiani RB
    BMC Med Genomics; 2014 Dec; 7():68. PubMed ID: 25496125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum hsa-miR-30e As a Potential Biomarker to Predict the Effect of Neoadjuvant Chemoradiation Therapy in Locally Advanced Rectal Cancer.
    Chen W; Wang W
    Genet Test Mol Biomarkers; 2021 Nov; 25(11):696-706. PubMed ID: 34788143
    [No Abstract]   [Full Text] [Related]  

  • 9. The Role of Micro-RNAs and Circulating Tumor Markers as Predictors of Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer.
    De Palma FDE; Luglio G; Tropeano FP; Pagano G; D'Armiento M; Kroemer G; Maiuri MC; De Palma GD
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32987896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of microRNA-199b predicts unfavorable prognosis and emerges as a novel therapeutic target which contributes to PP2A inhibition in metastatic colorectal cancer.
    Cristóbal I; Caramés C; Rincón R; Manso R; Madoz-Gúrpide J; Torrejón B; González-Alonso P; Rojo F; García-Foncillas J
    Oncotarget; 2017 Jun; 8(25):40169-40180. PubMed ID: 27517624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum miR-125b is a non-invasive predictive biomarker of the pre-operative chemoradiotherapy responsiveness in patients with rectal adenocarcinoma.
    D'Angelo E; Fassan M; Maretto I; Pucciarelli S; Zanon C; Digito M; Rugge M; Nitti D; Agostini M
    Oncotarget; 2016 May; 7(19):28647-57. PubMed ID: 27081702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-19b Plays a Key Role in 5-Fluorouracil Resistance and Predicts Tumor Progression in Locally Advanced Rectal Cancer Patients.
    Santos A; Cristóbal I; Rubio J; Caramés C; Luque M; Sanz-Álvarez M; Zazo S; Madoz-Gúrpide J; Rojo F; García-Foncillas J
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of miR-199b is associated with distant metastasis in colorectal cancer via activation of SIRT1 and inhibition of CREB/KISS1 signaling.
    Shen ZL; Wang B; Jiang KW; Ye CX; Cheng C; Yan YC; Zhang JZ; Yang Y; Gao ZD; Ye YJ; Wang S
    Oncotarget; 2016 Jun; 7(23):35092-105. PubMed ID: 27145368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and Kinetic Analyses of Circulating Tumor Cells as Predictive Markers of Treatment Response in Locally Advanced Rectal Cancer Patients.
    Troncarelli Flores BC; Souza E Silva V; Ali Abdallah E; Mello CAL; Gobo Silva ML; Gomes Mendes G; Camila Braun A; Aguiar Junior S; Thomé Domingos Chinen L
    Cells; 2019 Jun; 8(7):. PubMed ID: 31247977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-194 as predictive biomarker of responsiveness to neoadjuvant chemoradiotherapy in patients with locally advanced rectal adenocarcinoma.
    D'Angelo E; Zanon C; Sensi F; Digito M; Rugge M; Fassan M; Scarpa M; Pucciarelli S; Nitti D; Agostini M
    J Clin Pathol; 2018 Apr; 71(4):344-350. PubMed ID: 28870889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Expression of microRNA-199b-5p Associates with Poor Prognosis Through Promoting Cell Proliferation, Invasion and Migration Abilities of Human Osteosarcoma.
    Zeng H; Zhang Z; Dai X; Chen Y; Ye J; Jin Z
    Pathol Oncol Res; 2016 Apr; 22(2):253-60. PubMed ID: 26183062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-31 Emerges as a Predictive Biomarker of Pathological Response and Outcome in Locally Advanced Rectal Cancer.
    Caramés C; Cristobal I; Moreno V; Marín JP; González-Alonso P; Torrejón B; Minguez P; Leon A; Martín JI; Hernández R; Pedregal M; Martín MJ; Cortés D; García-Olmo D; Fernández MJ; Rojo F; García-Foncillas J
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27271609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-199b-5p promotes malignant progression of osteosarcoma by regulating HER2.
    Chen Z; Zhao G; Zhang Y; Ma Y; Ding Y; Xu N
    J BUON; 2018; 23(6):1816-1824. PubMed ID: 30610808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic and clinicopathological value of miR-199b in cancers: a meta-analysis.
    Mao Z; Liu R; Zhang M; Liu W; Li D; Li H
    Biomark Med; 2022 Aug; 16(11):879-888. PubMed ID: 35704299
    [No Abstract]   [Full Text] [Related]  

  • 20. Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy.
    Drebber U; Lay M; Wedemeyer I; Vallböhmer D; Bollschweiler E; Brabender J; Mönig SP; Hölscher AH; Dienes HP; Odenthal M
    Int J Oncol; 2011 Aug; 39(2):409-15. PubMed ID: 21567082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.